A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show ...

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...

The US Food and Drug Administration (FDA) has approved aflibercept injection 8 mg (EYLEA HD) from Regeneron Pharmaceuticals ...

The overall dry AMD market size in the US is anticipated to increase, due to the uptake of recently approved therapies, the launch of emerging therapies such as Gildeuretinol (Alkeus Pharmaceuticals), ...

A laser treatment for this common eye disease will start clinical trials in Finland next spring ––researchers hope it could be available to sufferers in as little as three years Around a third of ...

GENEVA--(BUSINESS WIRE)-- Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced its intention to acquire LumiThera, Inc., a leader in light-based ...

Heparan sulfate in Bruch’s membrane is a major player in early age-related macular degeneration (AMD) by trapping lipoproteins and kickstarting drusen formation. Targeting this sticky interaction ...

This week, Bobbi Conner talks with Dr. Mauricio Pereira about the diagnosis and treatment of macular degeneration. Dr. Pereira is a Clinical Associate Professor of Ophthalmology and he’s a retinal ...

Conditions that resemble age-related macular degeneration (AMD) can differ considerably from AMD regarding prognosis, inheritance, monitoring and therapy. Differential diagnoses of AMD include other ...

Please provide your email address to receive an email when new articles are posted on . A 32-year-old woman was referred by the rheumatology service for a second opinion regarding high-risk medication ...